The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling
Open accessAbstract
Angiotensin II (AII) is a major determinant of arterial pressure and volume homeostasis, mainly because of its vascular action via the AII type 1 receptor (AT1R). AII has also been implicated in the development of cardiac hypertrophy because angiotensin I-converting enzyme inhibitors and AT1R antagonists prevent or regress ventricular hypertrophy in animal models and in human. However, because these treatments impede the action of AII at cardiac as well as vascular levels, and reduce blood pressure, it has been difficult to determine whether AII action on the heart is direct or a consequence of pressure-overload. To determine whether AII can induce cardiac hypertrophy directly via myocardial AT1R in the absence of vascular changes, transgenic mice overexpressing the human AT1R under the control of the mouse α-myosin heavy chain promoter were generated. Cardiomyocyte-specific overexpression of AT1R induced, in basal conditions, morphologic changes of myocytes and nonmyocytes that mimic those observed during the development of cardiac hypertrophy in human and in other mammals. These mice displayed significant cardiac hypertrophy and remodeling with increased expression of ventricular atrial natriuretic factor and interstitial collagen deposition and died prematurely of heart failure. Neither the systolic blood pressure nor the heart rate were changed. The data demonstrate a direct myocardial role for AII in the development of cardiac hypertrophy and failure and provide a useful model to elucidate the mechanisms of action of AII in the pathogenesis of cardiac diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sadoshima, J.-I., Xu, Y., Slayter, H. S., & Izumo, S. (1993) · Cell · doi:10.1016/0092-8674(93)90541-w · Cited by 1,348
Brilla, C. G., Zhou, G., Matsubara, L., & Weber, K. T. (1994) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1994.1098 · Cited by 694
Transgenic Gαq overexpression induces cardiac contractile failure in mice
D’Angelo, D. D., Sakata, Y., Lorenz, J. N., Boivin, G. P., Walsh, R. A., Liggett, S. B., & Dorn, G. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.8121 · Cited by 629
Agah, R., Frenkel, P. A., French, B. A., Michael, L. H., Overbeek, P. A., & Schneider, M. D. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119509 · Cited by 606
Survey of Studies Examining Mammalian Cardiomyocyte DNA Synthesis
Soonpaa, M. H., & Field, L. J. (1998) · Circulation Research · doi:10.1161/01.res.83.1.15 · Cited by 558
Enhanced Gαq signaling: A common pathway mediates cardiac hypertrophy and apoptotic heart failure
Adams, J. W., Sakata, Y., Davis, M. G., Sah, V. P., Wang, Y., Liggett, S. B., Chien, K. R., Brown, J. H., & Dorn, G. W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.10140 · Cited by 525
Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction.
Nio, Y., Matsubara, H., Murasawa, S., Kanasaki, M., & Inada, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117675 · Cited by 435
Endothelin-1 Is Involved in Mechanical Stress-induced Cardiomyocyte Hypertrophy
Yamazaki, T., Komuro, I., Kudoh, S., Zou, Y., Shiojima, I., Hiroi, Y., Mizuno, T., Maemura, K., Kurihara, H., Aikawa, R., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.6.3221 · Cited by 395
Transcriptional Regulation During Cardiac Growth and Development
Chien, K. R., Zhu, H., Knowlton, K. U., Miller-Hance, W., Van-Bilsen, M., O'Brien, T. X., & Evans, S. M. (1993) · Annual Review of Physiology · doi:10.1146/annurev.ph.55.030193.000453 · Cited by 370
Molecular and Cellular Mechanisms of Myocardial Failure
Colucci, W. S. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00845-x · Cited by 322
Cited by
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
de Gasparo, M., Catt, K. J., Inagami, T., Wright, J. W., & Unger, T. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01458-3 · Cited by 2,132
Cardiac Hypertrophy: The Good, the Bad, and the Ugly
Frey, N., & Olson, E. N. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142243 · Cited by 1,449
Bernardo, B. C., Weeks, K. L., Pretorius, L., & McMullen, J. R. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.04.005 · Cited by 894
The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice
Bueno, O. F. (2000) · The EMBO Journal · doi:10.1093/emboj/19.23.6341 · Cited by 774
Li, D., Shinagawa, K., Pang, L., Leung, T. K., Cardin, S., Wang, Z., & Nattel, S. (2001) · Circulation · doi:10.1161/hc4601.099402 · Cited by 703
Is atrial fibrillation an inflammatory disorder?
Boos, C. J., Anderson, R. A., & Lip, G. Y. H. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi645 · Cited by 552
Bendall, J. K., Cave, A. C., Heymes, C., Gall, N., & Shah, A. M. (2002) · Circulation · doi:10.1161/hc0302.103712 · Cited by 530
Congestion in Acute Heart Failure Syndromes: An Essential Target of Evaluation and Treatment
Gheorghiade, M., Filippatos, G., De Luca, L., & Burnett, J. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.09.011 · Cited by 426
Tissue Renin-Angiotensin-Aldosterone Systems: Targets for Pharmacological Therapy
Bader, M. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105610 · Cited by 345
Molecular regulation of cardiac hypertrophy
Barry, S. P., Davidson, S. M., & Townsend, P. A. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.02.020 · Cited by 306
G-Protein–Coupled Receptors in Heart Disease
Wang, J., Gareri, C., & Rockman, H. A. (2018) · Circulation Research · doi:10.1161/circresaha.118.311403 · Cited by 303
Karnik, S. S., Unal, H., Kemp, J. R., Tirupula, K. C., Eguchi, S., Vanderheyden, P. M. L., & Thomas, W. G. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.010454 · Cited by 302
Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity
Aries, A., Paradis, P., Lefebvre, C., Schwartz, R. J., & Nemer, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401833101 · Cited by 296
Self-citationUpdate on tissue renin–angiotensin systems
Bader, M., & Ganten, D. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0336-0 · Cited by 293
Bader, M., Peters, J., Baltatu, O., Müller, D. N., Luft, F. C., & Ganten, D. (2001) · Journal of Molecular Medicine · doi:10.1007/s001090100210 · Cited by 279
Angiotensin receptors: distribution, signalling and function
DINH, D. T., FRAUMAN, A. G., JOHNSTON, C. I., & FABIANI, M. E. (2001) · Clinical Science · doi:10.1042/cs1000481 · Cited by 268
Xiao, H. D., Fuchs, S., Campbell, D. J., Lewis, W., Dudley, S. C., Kasi, V. S., Hoit, B. D., Keshelava, G., Zhao, H., Capecchi, M. R., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63363-9 · Cited by 264
ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy
Gallo, S., Vitacolonna, A., Bonzano, A., Comoglio, P., & Crepaldi, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092164 · Cited by 264
Marchesi, C., Ebrahimian, T., Angulo, O., Paradis, P., & Schiffrin, E. L. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.138305 · Cited by 261
Self-citationLeft Ventricular Hypertrophy and Clinical Outcomes in Hypertensive Patients
Ruilope, L. M., & Schmieder, R. E. (2008) · American Journal of Hypertension · doi:10.1038/ajh.2008.16 · Cited by 258
Guilluy, C., Brégeon, J., Toumaniantz, G., Rolli-Derkinderen, M., Retailleau, K., Loufrani, L., Henrion, D., Scalbert, E., Bril, A., Torres, R. M., et al. (2010) · Nature Medicine · doi:10.1038/nm.2079 · Cited by 256
Abdi, A., AlOtaiby, S., Badarin, F. A., Khraibi, A., Hamdan, H., & Nader, M. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112518 · Cited by 47
Metadata
- Authors
- Paradis, P., Dali-Youcef, N., Paradis, F. W., Thibault, G., & Nemer, M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2000-01-18
- Volume
- 97
- Issue
- 2
- Pages
- 931-936
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2085250186
- Cited by
- 382
- References
- 40
- FWCI
- 16.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.